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Summary 
Activation of human thymocytes and pre-B cells via the CD3/T cell receptor (TCR) complex 
or the IgM/B cell receptor complex, respectively, results in apoptotic cell death. Similarly, cross- 
linking of the activation marker CD69,  which belongs to the natural killer complex, causes 
apoptosis of lipopolysaccharide-preactivated monocytes. Here we show that pertussis toxin (PTX) 
inhibits the activation-induced apoptosis of these three cell types, though it fails to prevent the 
programmed cell death that follows exposure of cells to the synthetic glucocorticoid dexamethasone 
(thymocytes, pre-B cells)  or to interleukin 4  (monocytes). The capacity of pertussis toxin to 
suppress activation-induced death is not due to quenching of the activation signal, because thymocytes 
exposed to PTX are still capable of mobilizing Ca  2+ after TCR-ot/B cross-linking and proliferate 
in response to costimulation with PTX and CD3/TCR ligation. The apoptosis-inhibitory effect 
of PTX depends on the presence of an intact adenosine diphosphate (ADP)-ribosylating moiety, 
since a mutant pertussis toxin molecule that lacks enzymatic activity, but still possesses the membrane 
translocating activity, fails to interfere with activation-induced cell death. A toxin that induces 
a different spectrum of ADP ribosylation than PTX, cholera toxin, fails to inhibit apoptosis. 
To suppress apoptosis,  the intact PTX holotoxin must be added to cells before the lethal activation 
step; its addition 30 min after initial activation remains without effect on apoptosis.  These data 
unravel a PTX sensitive signal transduction event that intervenes during an early step of activation- 
induced cell death of immune cells. 
~  optosis or programmed cell death concerns immune cells 
exposed to specific activation signals that are delivered 
via the antigen receptor, alternative activation pathways, en- 
dogenous immunosuppressive molecules (e.g., glucocorticoids, 
transforming growth factor), cytotoxic effector molecules (e.g., 
granzymes, TNF), or a deficiency in obligate trophic factors 
(1). A genetically determined or acquired resistance to apop- 
tosis  induction may participate in lymphoproliferative and 
autoimmune diseases, as well as in the genesis of leukemias 
or lymphomas. In contrast, an excessive apoptotic decay of 
lymphoid cells is likely to be involved in the pathogenesis 
of acute virus-induced immunodepression (2, 3), as well as 
in chronic AIDS-associated lymphopenia (4,  5).  Given the 
probable role of apoptosis in immunodeficiency, strategies de- 
signed to avoid lymphocyte apoptosis could have a prophylactic 
effect on progressive lymphocyte depletion. With these facts 
in mind, and to dissect the mechanisms involved in apoptosis 
regulation, we and others are presently searching substances 
capable of inhibiting lymphocyte apoptosis  (6). 
Here,  we show  that  pretreatment with  pertussis  toxin 
(PTX) inhibits the subsequent activation-induced apoptosis 
of three cell types that  are notoriously prone to apoptosis 
induction: thymocytes, pre-B leukemia ceils, and monocytes. 
However, PTX pretreatment fails to prevent death induced 
by other stimuli such as glucocorticoids (thymocytes, pre-B 
cells) or the cytokine IL-4 (monocytes). The inhibitory effect 
of PTX on activation-induced death depends on the presence 
of intact ADP-ribosyltransferase activity, thereby implying 
G protein(s) in the regulation of apoptosis of immunologi- 
cally relevant cells. 
Materials and Methods 
Isolation of Cell Populations.  Thymocyte suspensions were ob- 
tained from thymus fragments removed during corrective surgery 
from 1-12-too-old patients. Double negative (CD4-CD8-), single 
positive  (CD4+CD8 -  or  CD4-CD8+),  and  double  positive 
(CD4 +  CD8 +) thymocyte populations were isolated by negative 
and/or sequential  positive selection steps with antibodies (anti-CD4, 
anti-CD8c~) coupled to magnetic beads according to the manufac- 
turer's instructions (Dynabeads M450; Dynal, Oslo, Norway). To 
detach beads from positively selected thymocyte populations, cells 
were incubated during 8-12 h at 37~  in complete culture medium. 
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moved by Ficoll Hypaque gradient centrifugation. The purity of 
the different subsets assessed by immunofluorescence analysis  was 
>90%,  and viability was >98%.  Monocytes were isolated from 
heparinized peripheral blood of healthy adult donors. Buffy coat 
cells were subjected to differential gradient centrifugation (Ficoll/ 
Hypaque; Pharmacia LKB,  Uppsala, Sweden) to enrich monocytes 
and enriched for CD14 + expression (Dynabeads). Pre-B leukemia 
cells (IgM+IgD +) were obtained from peripheral blood of a 69-yr- 
old male patient.  Blood leukocytes were depleted from CD3 +, 
CD5 +, and CD56 § cells (Dynabeads), as well as plastic-adherent 
cells (12 h, 37~  The phenotype of these cells was determined 
to be CD5 § (41%) CD19 § (71%) CD20 § (30%) CD21-CD22 § 
(27%) CD24-  and HLA-DR  + (89%). 
Culture Conditions.  Cells  were cultured at the indicated  concen- 
tration in RPMI 1640 medium supplemented with 2 mM L-glu- 
tamine, 10 mM Hepes, 10% FCS, and antibiotics (200 #l/well in 
flat-bottomed  96-well microtiter plates; Nunc, RJoskilde,  Denmark). 
To induce apoptosis in thymocytes, cells were exposed to plastic- 
bound anti-CD3 (Leu 4b; Serotec Ltd., Oxford,  UK; 20/~g/ml 
in 50/~l/well PBS containing 0.1% BSA incubated for 4 h at 37~ 
followed by three washes with PBS). 4 h after starting cell cul- 
tures, anti-TCR-o~//~  mAb (TA 1043, 2/zg/ml; T Cell Diagnostics, 
Cambridge, UK) was added. Alternatively, thymocytes were ex- 
posed for 24 h to 0.1 #M dexamethasone (DEX). Pre-B leukemia 
cells were exposed during 18-24 h to plastic-immobilized  anti-IgM 
mAb (SERT 116; Serotec  Ltd. ). I h after addition to plastic-bound 
anti-IgM, an anti-CD19 mAb 04.119, 2 #g/ml; Serotec) (7) was 
added to wells. Alternatively, cell death was induced by culture 
with DEX (1/~M). Monocytes were preactivated in the presence 
of  LPS (from Escherichia  coli, 25 ng/ml, 12 h at 37~  Sigma Chem- 
ical Co., Poole, UK). After three washes (600 g, 10 min, at room 
temperature) cells were exposed to anti-CD69 (MCA736, 2/zg/ml; 
Serotec Ltd.) or to recombinant human IL-4 (500 U/ml; British 
Biotechnology, Oxford, UK) (8). In most experiments, cells were 
cultured for 30 min in the presence of PTX (100 ng/ml; Sigma 
Chemical Co.), followed by three washes (600 g, 10 rain at room 
temperature), to prevent the induction of apoptosis. A mutant PTX 
molecule (mPTX; PTgK 129G, 100 ng/ml, reference 9), cholera 
toxin (1/~g/ml; Sigma Chemical Co.), or incubation in medium 
only served as controls. 
Proliferation Assays, Assessment of Apoptotic Cell Death, Determi- 
nation oflntracellular Calcium.  Proliferation  was measured after ad- 
dition of 1 #Ci/well of [3H]thymidine (Amersham International, 
Little Chalfort,  UK) during the last 18 h of culture. Apoptosis 
was  quantitated  by three  different methods:  (a)  Mayer (Azur 
II/Eosin) staining of cytospin preparations allowing for the detec- 
tion of apoptotic morphology;  (b) assessment of the apoptosis- 
associated increase in membrane permeability  for propidium iodine; 
or (c) determination of oligonucleosomal DNA fragmentation on 
horizontal agarose gels (3). To measure the mobilization of intra- 
cellular calcium, PTX,  and/or  anti-CD3-treated  CD4+CD8 + 
thymocytes  were loaded  with quin-2-tretrakis(acetomethyl)ester  (2.5 
#g/ml; Molecular Probes Inc., Eugene, OR.) and stimulated with 
soluble anti-TCR-cr//~ (2/zg/ml). Fluorescence of individual cells 
was measured  using a microscope (Axiovert 35; Zeiss Ltd., Welwyn 
Garden City, UK). 
Results and Discussion 
PTX Selectively Inhibits the TCR/CD3-induced Apoptosis of 
Human  Thymocytes.  A  significant  percentage  of human 
thymocytes undergoes apoptosis after sequential activation 
of the CD3e  and the TCR complexes.  Using a system in 
which purified thymocyte subpopulations were exposed  to 
immobilized anti-CD3ol during a 4-h culture period, followed 
by addition of a mAb specific for the TCR-oJ~8 (10), we 
observed  that CD4+CD8 +  and CD4+CD8 -  thymocytes 
are  more  susceptible  to  apoptosis  induction than  CD4- 
CD8 + or CD4-CD8-  cells (Fig.  1 A).  Preincubation of 
these thymocyte subpopulations with PTX for a minimum 
of 30 rain completely prevents the CD3/TCR-mediated in- 
duction of apoptosis (Fig. 1, A and B) and apoptosis-associated 
DNA fragmentation (Fig.  1 C).  This apoptosis-inhibitory 
effect is specific for activation-induced death, because PTX 
does not block the glucocorticoid (DEX)-induced death of 
thymocytes (Fig.  1 A). PTX inhibits all signs of apoptosis 
induced via the anti-CD3/TCR complex: acquisition of apop- 
totic morphology (Fig. 1 A); loss of cell viability (Fig. 1 B); 
and DNA fragmentation (Fig.  1 C). 
The Apoptosis Inhibitory Effect of  PTX Requires Pretreatment 
and Depends on ADP Ribosyltransferase Activity.  As shown 
in Fig.  1 D,  to obtain an apoptosis-inhibitory effect, PTX 
must be added to thymocytes shortly before the lethal activa- 
tion signal is provided. Addition of PTX together with the 
CD3-cross-linking antibody is far less effective than PTX 
pretreatment, and addition of PTX as little as 30 min after 
CD3 cross-linking is completely inefficient in preventing apop- 
tosis. Resting of cells at 37~  for more than 150 rain after 
incubation of cells with the PTX standard dose (100 ng/ml, 
30  rain),  before  CD3/TCR  cross-linking,  abolishes  the 
apoptosis-inhibitory  effect of  PTX, indicating that the changes 
induced by PTX are reversible. The antiapoptotic effect of 
PTX critically depends on its ADP ribosyltransferase activity, 
as revealed by analysis of a mutant PTX (mPTX) molecule. 
The mutant PTX holotoxin PT9K 129G (mPTX) lacks this 
enzymatic activity due to two amino acid substitutions in 
the $1 subunit (residues 9 and 129), though conserves its overall 
tertiary and quaternary structure and retains its cell-binding 
and membrane translocation potentials, as well as T cell-mito- 
genic and hemagglutinating activities (9). mPTX fails to in- 
hibit activation-induced thymocyte death (Fig. 1, A and D), 
indicating that the ADP-ribosylating activity of PTX is es- 
sential for its  apoptosis-inhibitory effect.  Pretreatment of 
thymocytes with another ADP-ribosylating toxin, the ex- 
otoxin elaborated by cholera toxin (1/~g/ml, 30 min) that 
covalently modifies a different set of G proteins than PTX 
(11), has no effect on the induction of apoptosis  (Fig.  1 D). 
Failure of PTX  to Inhibit  TCR-mediated  Signal  Transduc- 
tion.  To  exclude the possibility that  PTX  might inhibit 
activation-induced cell death by grossly perturbing cellular 
metabolism and/or signal transduction, we studied the effect 
of preincubation with PTX on TCR-triggered intracellular 
signals. TCR-induced calcium mobilization was not affected 
by prior exposure to PTX (Fig.  2 A). Another indication 
that 7FX does not perturb TCR-mediated signal transduc- 
tion comes from the observation that CD4+CD8 + thymo- 
cytes stimulated with PTX plus anti-CD3/TCR exhibit a 
higher  incorporation  of [3H]thymidine than controls  ex- 
posed to PTX or anti-CD3/TCR only. In contrast to intact 
PTX, mPTX is not comitogenic in this system (Fig.  2 B). 
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transduction  and  cell  cycle progression. 
PTX Inhibits Anti-IgM-  but not IL-4-induced Apoptosis of 
Human Pre-B Leukemia Cells.  Leukemia cells bearing a pre- 
B cell phenotype were pretreated in the absence or presence 
of PTX  (or mPTX  as a control),  followed by cross-linking 
of the IgM antigen  receptor,  as well as CD19.  In this  type 
ofpre-B leukemias, only a combination of anti-IgM or CD19 
cross-linking was found to induce a significant (>10%) apop- 
totic index. Whereas a significant percentage of cells pretreated 
with medium only (or mPTX as a control) undergoes apop- 
tosis after exposure to anti-IgM/CD19,  pre-B leukemia cells 
pretreated with intact PTX fail to do so (Fig. 3). PTX-mediated 
resistance  to  apoptosis  induction  is  restricted  to  anti- 
IgM/CD19 triggered death and does not extend to death in- 
duced  by DEX  (Fig.  3). 
PTX Inhibits the Activation-induced Death of  Monocytes.  As 
shown in Fig. 4 A, LPS-preactivated monocytes undergo apop- 
tosis if they are stimulated with an antibody specific for the 
activation antigen  CD69  that belongs  to the  NK complex 
(12).  Only  a  combination  of LPS  pretreatment  and  CD69 
cross-linking but not either of these manipulations alone in- 
duce apoptosis of a  significant percentage of cells.  Again,  a 
short (30 min) preincubation step with PTX (but not m/fiX) 
has a selective apoptosis inhibitory effect, rescuing monocytes 
from anti-CD69-induced  cell death.  In contrast,  PTX does 
not inhibit the death of LPS-pretreated monocytes incubated 
in  the  presence  of IL-4  (Fig.  4  A)  (8),  thus  unraveling  a 
dichotomy between two death pathways operating in mono- 
cytes, one that is PTX-sensitive and mediated via CD69 and 
another that is PTX-resistant and triggered via IL-4 receptors. 
Concluding Remarks.  As to the mechanism by which PTX 
selectively impedes  activation-induced  death,  two  observa- 
tions may be relevant. First, only pretreatment of cells with 
Figure 1.  PTX inhibits activation-induced thymocyte apoptosis. (A) 
Effect on apoptotic cell death induced in purified thymocyte populations. 
Purified human thymocyte subpopulations were incubated for 30 min in 
PTX (100 ng/ml), a mutant PTX derivate lacking ADP-ribosylating ac- 
tivity (mFTX,  100 ng/ml) or medium only (0), washed three times and 
exposed to immobilized anti-CD3E (0-24 h) and soluble anti-TCR-cd/5 
mAbs (12-24 h) to induce cell death. Alternatively, apoptotic death was 
induced by DEX. Black squares symbolize the execution of the indicated 
treatment. Apoptosis was quantitated on Mayer-stained  cytospin prepara- 
tions by morphological criteria after 24 h of  culture. Mean results (+ SEM) 
out of five different experiments are shown. Asterisks  indicate significant 
effects (p <0.01, unpaired Student's t test) of PTX as compared with con- 
trois cultured in the absence of FFX or in the presence of mPTX. (B) 
Effect  of  FTX  pretreatment  on  anti-CD3/TCR-induced  death  of 
CD4+CD8 + cells. Cells pretreated in the presence or absence of FTX 
were stimulated by sequential treatment with anti-CD3e and anti-TCR- 
or//3 (same treatment  as in A). After 24 h cell viability was determined 
by staining  with propidium iodine. (C) Effect  of  PTX on apoptosis-associated 
DNA fragmentation. CD4+CD8 + thymocytes were preincubated with 
PTX and/or were stimulated sequentially  via the CD3 and the TCR-c~//3. 
DNA from 106 cells was analyzed by agarose gel electrophoresis and 
staining with ethidium bromide. (/9) Time-dependence of the PTX effect. 
Apoptosis was induced in CD4+CD8 + thymocytes as in A, i.e., by ex- 
posure of cells to plastic-bound anti-CD3 (0-24 h) and soluble anti-TCR- 
cx//3 (4-24 h). To prevent the induction or execution of cell death, cells 
were preincubated during the indicated intervals before stimulation with 
anti-CD3 mAb (negative symbols) in the presence of PTX (100 rig/m1, 
37~  30 min), mPTX (same  concentration and treatment) or cholera toxin 
(CTX; 1 #g/ml) followed by washing and incubation at 37~  until the 
addition of  cells to anti-CD3-coated microtiter plates. Alternatively, PTX 
was added together (0) or after (positive symbols) incubation of calls with 
an immobilized anti-CD3 antibody. Mutant FFX or incubation in medium 
served as controls. Values of apoptosis obtained for ceUs  with medium only 
were constant  (range: 41-50%). 
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Figure  2.  PTX  does not inhibit TCR-triggered T cell activation. 
(A)Effect of PTX  on  anti-TCR-ot/3 induced calcium mobilization. 
CD4+CD8 + thymocytes  having  been exposed to PTX or control cells 
were stimulated  during  a 4-h period with plastic-bound  anti-CD3. After 
loading with quin-2, cells  were stimulated  with anti-TCR-od3  to mobi- 
lize intracellular  calcium. Results are typical for 50 individual  measure- 
ments. (B) Effect of PTX on thymocyte  proliferation. Cells were pres- 
timulated  with PTX and/or  stimulated  with anti-CD3  plus anti-TCR-od3 
during 72 h. [3H]thymidine  incorporation was assessed during the last 
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Figure 4.  PTXinhibitsactivation-indueedcelldeathofmonocytes.  LPS- 
preactivated or control monocytes  were preincubated for 30 min in PTX 
(100 ng/ml), mPTX, or medium only, followed  by apoptosis induction 
with II~4 or anti-CD69. DNA hypoploidy  was assessed 18 h later. Mean 
values of four different  experiments are shown. Asterisks mark significant 
PTX effects. 
PTX inhibits activation-induced cell death, indicating that 
it has to interfere with an early step in the apoptosis inducing 
cascade and/or reprogram per se apoptosis-susceptible cells 
towards a  refractory state.  Second,  to  exert  its  activation 
death-inhibitory effect, the PTX molecule has to contain an 
intact ADP-ribosylating moiety. The PTX holotoxin is com- 
posed of five different subunits ($1-$5). The S1 subunit ADP- 
ribosylates PTX-sensitive  Got subunits so that ligand-induced 
exchange of GDP for GTP on the Go~ subunit is blocked. 
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Figure 3.  PTX inhibits the antigen  receptor-triggered death of pre-B 
leukemia cells. Pre-B leukemia cells were incubated  during 24 h in the 
presence of the indicated  stimulus,  followed  by determination  of the fie- 
quency  of apoptotic cells. Mean  values (_+ SEM) of four independent  ex- 
periments from  cells of the same patient are shown. Resu]ts  are represen- 
tative for three different  patients.  Asterisks  mark significant  PTX effects. 
It thus interferes with Gi-protein-dependent signal transduc- 
tion from cell surface receptors. The B oligomer of PTX (made 
up of the $2-$5 subunits) alone has several biological effects, 
namely T cell mitogenicity, IL-2 induction (13, 14), and down- 
modulation of the TCR/CD3 complex (15, 16). Given that 
these effects do not require ADP ribosyl transferase activity, 
it is improbable that they determine the antiapoptotic potential 
of PTX. Moreover,  the incapacity of PTX to inhibit TCR- 
mediated calcium mobilization (Fig. 2 A) argues against the 
possibility that PTX inhibits activation-induced cell death 
by downmodulating functional TCD/CD3 signal transduc- 
tion modules (15, 16) or by quenching activation signals. It 
is improbable that PTX exerts its antiapoptotic effect by up- 
regulating cAMP levels (17), because elevation of cAMP in- 
duces DNA fragmentation of murine thymocytes (18). In 
addition, CTX,  another ADP ribosylating toxin that also 
causes cAMP elevations, fails to inhibit thymocyte apoptosis 
(Fig.  1 D). 
PTX has a strong proautoimmune effect. It accelerates the 
development of spontaneous autoimmunity (19) and elicits 
organ-specific autoimmune diseases when coadministered to- 
gether with the relevant  autoantigen (19, 20).  This proau- 
toimmune effect may be hypothetically ascribed  to the ca- 
pacity of PTX to interfere with clonal deletion. PTX inhibits 
activation-induced cell death of human thymocytes and pre-B 
cells, thus acting in an experimental setting that is thought 
to mimic negative selection in the thymus or in the bone 
marrow (this paper).  Similarly, it inhibits the superantigen- 
mediated deletion of peripheral T cells in an in vivo mouse 
model without interfering with other biological effects of 
superantigens such as lymphokine secretion and T cell prolifer- 
ation (21). In this context it may be intriguing that, in the 
mouse, a locus controlling the in vivo responsiveness to IrI'X 
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bility to certain organ-specific autoimmune diseases including 
experimental autoimmune orchitis and encephalomyelitis, a 
model of multiple sclerosis (22). In addition, it has recently 
been shown that peripheral T lymphocytes from patients with 
sarcoidosis, i.e., a disease with a putative autoimmune com- 
ponent, exhibit a selective defect in the major substrate of 
PTX-mediated ADP ribosylation (23).  These observations 
strongly suggest the involvement of I:TX-sensitive G  pro- 
teins in the control of the function of the normal immune 
system. By preventing activation-induced cell death, geneti- 
cally determined or acquired defects in PTX-sensitive G pro- 
teins could lead to the uncontrolled proliferation/accumula- 
tion of self-reactive lymphocytes or tissue macrophages. 
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